XML 60 R44.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Deficit), Temporary Equity and Noncontrolling Interests (Details) - USD ($)
 1 Months Ended 6 Months Ended
Jun. 18, 2020
Jun. 09, 2020
Jan. 15, 2020
Jun. 30, 2020
Apr. 30, 2020
Feb. 29, 2020
Jan. 31, 2020
Dec. 23, 2019
Jun. 30, 2020
May 31, 2020
Dec. 31, 2019
May 14, 2019
Feb. 01, 2019
Stockholders Equity Note [Line Items]                          
Preferred stock, shares authorized       10,000,000         10,000,000   10,000,000    
Preferred stock, par value       $ 0.0001         $ 0.0001   $ 0.0001    
Preferred stock, shares issued                    
Preferred stock, shares outstanding                    
Authorized common stock       31,250,000         31,250,000 250,000,000 250,000,000    
Common stock, par value       $ 0.0001         $ 0.0001   $ 0.0001    
Common stock, shares authorized       250,000,000         250,000,000   250,000,000    
Common stock, shares issued       5,009,508         5,009,508   3,619,658    
Common stock, shares outstanding       5,009,508         5,009,508   3,619,658    
Recognized compensation expense                 $ 318,473        
Mr. Sohn [Member]                          
Stockholders Equity Note [Line Items]                          
Restricted common stock, description The RSUs will vest over a two-year period from the date of the Uplisting in equal quarterly installments on the last day of each calendar quarter, with the first portion vesting on the last day of the calendar quarter during which the Uplisting takes place, subject to Mr. Sohn serving as an executive officer of the Company on each applicable vesting date, provided that the RSUs shall vest in full immediately upon the termination of Mr. Sohn's employment by the Company without Cause (as defined in the Employment Agreement). The RSU award has been valued at $1,662,000 and compensation expense will be recorded over the estimated vesting period. We recognized compensation expense of $30,218 during the three and six months ended June 30, 2020, respectively. The shares have not been issued at June 30, 2020.                        
Restricted common stock shares 554,000                        
Series D Preferred Stock [Member]                          
Stockholders Equity Note [Line Items]                          
Preferred stock, shares authorized       2,000,000         2,000,000   2,000,000    
Preferred stock, par value       $ 0.0001         $ 0.0001   $ 0.0001    
Preferred stock, shares issued       536,595         536,595   454,546    
Preferred stock, shares outstanding       536,595         536,595   454,546    
Preferred Stock as consideration for waivers of penalties                 106,134        
Number of shares issued upon conversion           161,250     157,000        
Preferred shares converted       12,560         12,560        
Aggregate additional shares                     106,134    
Conversion of shares           12,900              
Sale of stock sold, description   The Company sold 1,375 Series D preferred stock units (the "Units") at a purchase price of $18.1818 per Unit, taking into account a 10% discount, each Unit consisting of one share of Series D Preferred Stock and a warrant to purchase 6.25 shares of common stock, subject to adjustment as provided for therein. The Series D Preferred Stock sold in the financing converts into a minimum of 17,188 shares of common stock. The Company received gross proceeds of $25,000 from the sale of the Units. The 8,594 warrants are exercisable for five years from the issuance date at an exercise price of $4.80 per share, subject to adjustment as provided for therein.                      
Share of Series D Preferred Stock sold   1,375                      
Sale of preferred stock price per share   $ 18.1818                      
Gross proceeds from sale of units   $ 25,000                      
Series E Preferred Stock [Member]                          
Stockholders Equity Note [Line Items]                          
Preferred stock, shares authorized       775,000         775,000   775,000    
Preferred stock, par value       $ 0.0001         $ 0.0001   $ 0.0001    
Preferred stock, shares issued       731,845         731,845   734,986    
Preferred stock, shares outstanding       731,845         731,845   734,986    
Included in accrued expenses       $ 308,893         $ 308,893        
Shares issued             39,260            
Conversion of shares             3,141            
Series F Preferred Stock [Member]                          
Stockholders Equity Note [Line Items]                          
Preferred stock, shares authorized       200,000         200,000   200,000    
Preferred stock, par value       $ 0.0001         $ 0.0001   $ 0.0001    
Preferred stock, shares issued       64,382         64,382   139,768    
Preferred stock, shares outstanding       64,382         64,382   139,768    
Shares issued         138,926 803,414 803,414            
Preferred shares converted         11,114 64,272 64,272            
Included in accrued expenses       $ 308,893         $ 308,893        
Shares issued           803,414              
Conversion of shares           64,272              
Preferred Stock [Member]                          
Stockholders Equity Note [Line Items]                          
Preferred stock, shares authorized       10,000,000         10,000,000   10,000,000    
Preferred stock, par value       $ 0.0001         $ 0.0001   $ 0.0001    
Preferred stock, shares issued       1,332,822         1,332,822   1,329,300    
Preferred stock, shares outstanding       1,332,822         1,332,822   1,329,300    
Owed approximately penalties                     $ 6,000,000    
Value of shares issued                     1,929,516    
Included in accrued expenses       $ 308,798         $ 308,798   $ 2,238,314    
Common Stock [Member]                          
Stockholders Equity Note [Line Items]                          
Authorized common stock                   31,250,000      
Restricted common stock                         $ 43,423
Recognized compensation expense                 $ 12,665        
Common stock, description       The Company issued 157,000 shares of its common stock upon conversion of 12,560 shares of its Series D Preferred Stock. The Company issued 138,926 shares of its common stock upon conversion of 11,114 shares of Series F Preferred Stock. The Company issued 161,250 shares of its common stock upon conversion of 12,900 shares of its Series D Preferred Stock. The Company issued 39,260 shares of its common stock upon conversion of 3,141 shares of Series E Preferred Stock. The Company granted to a consultant 312,500 restricted stock units (the "RSUs") pursuant to a consultant agreement. The RSUs vest 63,500 upon grant with the balance vesting monthly in equal installments beginning January 1, 2020 and ending November 1, 2020, subject to the consultants continued service to the Company on each vesting date. The RSU award has been valued at $343,750 and compensation expense will be recorded over the respective vesting periods. We recognized compensation expense of $74,999 and $149,998 during the three and six months ended June 30, 2020, respectively. The shares have not been issued at June 30, 2020.          
Restricted common stock, description     Pursuant to the agreement the Company agreed to issue 30,000 shares of restricted common stock, earned monthly over the three month term of the agreement. The shares are fully vested upon issuance and have been valued at $45,500, based on the quoted market price of our common stock on the vesting dates. The shares were issued on April 3, 2020. We have recorded compensation expense of $6,500 and $45,500 during the three and six months ended June 30, 2020, respectively.                    
Restricted common stock shares     30,000                 451,170  
Common Stock [Member]                          
Stockholders Equity Note [Line Items]                          
Common stock, description             The Company issued 803,414 shares of its common stock upon conversion of 64,272 shares of Series F Preferred Stock.            
Restricted Common Stock [Member]                          
Stockholders Equity Note [Line Items]                          
Restricted common stock, description     Pursuant to the agreement the Company agreed to issue 60,000 shares of restricted common stock, plus a payment of $15,000. The shares are fully vested upon issuance and have been valued at $75,000, based on the quoted market price of our common stock on the grant date. The shares were issued on April 3, 2020. We have recorded compensation expense of $37,500 and $68,750 for the share portion of the agreement during the three and six months ended June 30, 2020, respectively, and expense of $7,500 and $13,750 for the cash portion during the three months ended June 30, 2020, respectively. Prepaid expense of $6,250 for the stock portion and $1,250 for the cash portion was recorded at June 30, 2020.